Beximco Pharmaceuticals (BXP) Stock Chart & Stock Price History GBX 34 +1.50 (+4.62%) (As of 11:13 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Beximco Pharmaceuticals Stock Price Performance 5 Day Performance+9.68%1 Month Performance+9.11%3 Month Performance0.00%6 Month Performance-14.16%Year-To-Date Performance-18.07%1 Year Performance-17.68% Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. BXP Stock Chart for Thursday, November, 21, 2024 BXP Chart by TradingView Beximco Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024GBX 32.50GBX 34+4.62%GBX 34GBX 32.5010,000 shs£151.68 million11/19/2024GBX 31.77GBX 32.50+2.30%GBX 33.97GBX 31.7728,147 shs£144.99 million11/18/2024GBX 31GBX 31.77+2.48%GBX 32GBX 31.0268,407 shs£141.73 million11/15/2024GBX 29.70GBX 31+4.38%GBX 31GBX 30237,101 shs£138.29 million11/14/2024GBX 29GBX 29.70+2.41%GBX 31GBX 28.75136,170 shs£132.50 million11/13/2024GBX 32.60GBX 29-11.04%GBX 31.03GBX 29210,892 shs£129.37 million Get the Latest News and Ratings for BXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024GBX 33.28GBX 32.60-2.04%GBX 34.50GBX 3190,171 shs£145.43 million11/11/2024GBX 33GBX 33.28+0.85%GBX 35GBX 3273,797 shs£148.47 million11/08/2024GBX 35GBX 33-5.71%GBX 35GBX 3276,797 shs£147.22 million11/07/2024GBX 31GBX 35+12.90%GBX 35GBX 34.9555,094 shs£156.14 million11/06/2024GBX 31GBX 31GBX 34.50GBX 3191,596 shs£138.29 million11/05/2024GBX 32GBX 31-3.13%GBX 32GBX 3146,487 shs£138.29 million11/04/2024GBX 31GBX 32+3.23%GBX 32GBX 3225,000 shs£142.76 million11/01/2024GBX 31.70GBX 31.96+0.82%GBX 31.96GBX 311,027 shs£142.58 million10/31/2024GBX 30.92GBX 31.70+2.52%GBX 31.70GBX 30.507,731 shs£141.42 million10/30/2024GBX 30.90GBX 30.92+0.07%GBX 30.92GBX 30.504,839 shs£137.95 million10/29/2024GBX 28.51GBX 30.90+8.38%GBX 30.94GBX 29.50146,516 shs£137.85 million10/28/2024GBX 29GBX 28.51-1.69%GBX 28.51GBX 28284,779 shs£127.19 million10/25/2024GBX 28.15GBX 29.94+6.36%GBX 30GBX 29.94182,338 shs£133.57 million10/24/2024GBX 29GBX 28.15-2.93%GBX 30GBX 28.1513,000 shs£125.58 million10/23/2024GBX 29.98GBX 29-3.25%GBX 30GBX 2986,655 shs£129.37 million10/22/2024GBX 31.16GBX 29.98-3.80%GBX 32GBX 29288,648 shs£133.72 million10/21/2024GBX 32GBX 31.16-2.63%GBX 33GBX 30.12236,894 shs£139.01 million Related Companies Prs Reit Stock Chart Pinewood Technologies Group Stock Chart Triple Point Social Housing REIT Stock Chart AdvancedAdvT Stock Chart Aurora Investment Trust Stock Chart Saga Stock Chart Celtic Stock Chart Corero Network Security Stock Chart TClarke Stock Chart Value and Indexed Property Income Stock Chart Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BXP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
